long mooted corporate interest??
Equity Investment and Buyback
Underpinning the partnership and reflecting its long-term focus and belief in the opportunity, Molson Coors will acquire an 8.5% shareholding in Fevertree Drinks plc (post-issue) for cash consideration of £71.0m (654.2 pence per share based on the 10-day VWAP). |
MAJOR SHAREHOLDING
This information was last updated on 30/11/2024.
NAME HOLDING %
Lindsell Train Investment Mgt 16,695,000 14.30
Fundsmith 7,189,823 6.16(now 4.89%)
Directors 6,058,524 5.19
FIL Ltd 5,837,306 5.00
Liontrust Asset Management 5,668,303 4.86
Capital Group 5,618,733 4.81
Charles Rolls 5,085,928 4.36
Nordflint Capital Partners 4,801,604 4.11
Baillie Gifford 3,732,234 3.20 |
the fall was arrested just after i posted on the 14th.
i admit it was starting to develop but a 30p intra day reversal may of stopped that
tiger |
I wonder if the chairman will buy another 45000 shares like he did around this time last year. Paid 9.47 at the time? |
Hi CTDoesn't look like it to me, looks like a nice bowl could be forming. |
Looks like the 500,s are coming |
I still can't see why such a high p.e. |
From today’s Times:
Re Diageo
‘The veteran investor Terry Smith offloaded his fund’s stake in the owner of Guinness and Johnnie Walker whisky over concerns that the development of anti-obesity drugs could reduce demand for alcohol.’ |
Fundsmith go below 5%. Terry puking it up at the bottom? |
still she drifts south |
Just got back from Australia, FT seems to be the mixer of choice and according to bar staff I spoke to, growing |
prices ( trade) going up April
tiger |
Nick Train ‘in pain’ over Diageo bet and fund performance
Presumably FEVR contributing to his ‘pain’. |
Imagine you are selling lemonade for one pound and the prices of ingredients mugs etc go up so much you only make a penny of profit. If you get the cups a penny cheaper and raise prices by a penny your profit is now 3 pence. Your profits have tripled. Now imagine you sell 33 percent more lemonade. Your profits have quadrupled. This is the principle of how this share could work out. |
What's half of market cap got to do with anything? This story is about margins and the cost of bottling etc. PEs will look high if the costs increase. These types of businesses have a few levers to pull to increase earnings. Cut the operating costs, which should happen now they have made progress with the bottling. Increase pricing, which they are doing and increase volume which seem to be doing. What's special about Fevertree though is that the people who buy it aren't that price sensitive. You could increase prices quite aggressively and people would still buy it. It may even be good for the brand. |
CTNot looked at Docs for a while as seemed to be getting way ahead of itself. If this FY profits are only a third of last year that's circa 2.5p eps, so on a fairly hefty PE IMO at 27x. That said if a recovery does play out (which I can't see tbh) the forecast earnings for FY26 are 5.4p, IMO a target price of say 80p (PE 15x), but better risks to rewards out there IMO.Will trump put the boot in with his tariffs?, then there's the issues here in the UK with min wage and NI etc. |
Hi CTHope all is good.Since Covid sales have been growing but yes net profit has been falling, but "has been" being the operative words. Net profit is forecast to double for FY24 with eps growth of 95%, giving a PE of 27x, and falling to a PE of 20x for FY25. A PEG of less than 1 for both FY24 and FY25.Margins are improving and whilst UK sales appear to be saturated it's not too concerning given mitigating growth in the US and ROW. |
ValueHurts
Not in the first half results they were flat.
last full year sales were up 20m to 364m which........ is LESS THAN HALF MARKET CAP
net profit fell £10m giving a p/e of 50+
I do understand that FEVR has never looked a sensible valuation.
The big concern is the UK sales are falling.
Tiger |
fidelity seem to want a tipple |
Sales are growing |
PROFITS ARE FALLING NOT GROWING
TIGER |
Bought a chunk of this again a week ago, great business great product and will continue growing. Let's hope the margins get sorted over the next few years. |
JPMorgan cuts Fevertree Drinks price target to 825 (900) pence - 'neutral' |
It is incredible that this is a share favoured by both Smith and Train. |
He is talked of in the pejorative because of regulatory failings at his firm. To compare to fevertree that has a net cash balance sheet and good liquidity is way off the mark imho |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
